Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 58 entries
Sorted by: Best Match Show Resources per page
Production of monodisperse silica gel microspheres for bioencapsulation by extrusion into an oil cross-flow.

Journal of microencapsulation

Benson JJ, Wackett LP, Aksan A.
PMID: 27358010
J Microencapsul. 2016 Aug;33(5):412-420. doi: 10.1080/02652048.2016.1202346. Epub 2016 Jun 29.

Silica gel microspheres are ideal materials for bioencapsulation due to their mechanical properties, biocompatibility, and stability. Encapsulated cells are isolated from the environment and protected from predators, changes in pH, and osmotic stress. However methods for the production of...

Cite
Benson JJ, Wackett LP, Aksan A. Production of monodisperse silica gel microspheres for bioencapsulation by extrusion into an oil cross-flow. J Microencapsul. 2016;33(5):412-420doi: 10.1080/02652048.2016.1202346.
Benson, J. J., Wackett, L. P., & Aksan, A. (2016). Production of monodisperse silica gel microspheres for bioencapsulation by extrusion into an oil cross-flow. Journal of microencapsulation, 33(5), 412-420. https://doi.org/10.1080/02652048.2016.1202346
Benson, Joey J, et al. "Production of monodisperse silica gel microspheres for bioencapsulation by extrusion into an oil cross-flow." Journal of microencapsulation vol. 33,5 (2016): 412-420. doi: https://doi.org/10.1080/02652048.2016.1202346
Benson JJ, Wackett LP, Aksan A. Production of monodisperse silica gel microspheres for bioencapsulation by extrusion into an oil cross-flow. J Microencapsul. 2016 Aug;33(5):412-420. doi: 10.1080/02652048.2016.1202346. Epub 2016 Jun 29. PMID: 27358010.
Copy Download .nbib Format: NLM
Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide.

Journal of microencapsulation

Bahari Javan N, Rezaie Shirmard L, Jafary Omid N, Akbari Javar H, Rafiee Tehrani M, Abedin Dorkoosh F.
PMID: 27424890
J Microencapsul. 2016 Aug;33(5):460-474. doi: 10.1080/02652048.2016.1208296. Epub 2016 Jul 17.

The purpose of this study was the preparation, optimisation and in vitro characterisation of PHBV and PLGA blend nanoparticles (NPs) for prolonged delivery of Teriparatide. Double emulsion solvent evaporation technique was employed for the fabrication of NPs. The nanoformulation...

Cite
Bahari Javan N, Rezaie Shirmard L, Jafary Omid N, et al. Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide. J Microencapsul. 2016;33(5):460-474doi: 10.1080/02652048.2016.1208296.
Bahari Javan, N., Rezaie Shirmard, L., Jafary Omid, N., Akbari Javar, H., Rafiee Tehrani, M., & Abedin Dorkoosh, F. (2016). Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide. Journal of microencapsulation, 33(5), 460-474. https://doi.org/10.1080/02652048.2016.1208296
Bahari Javan, Nika, et al. "Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide." Journal of microencapsulation vol. 33,5 (2016): 460-474. doi: https://doi.org/10.1080/02652048.2016.1208296
Bahari Javan N, Rezaie Shirmard L, Jafary Omid N, Akbari Javar H, Rafiee Tehrani M, Abedin Dorkoosh F. Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide. J Microencapsul. 2016 Aug;33(5):460-474. doi: 10.1080/02652048.2016.1208296. Epub 2016 Jul 17. PMID: 27424890.
Copy Download .nbib Format: NLM
Patent briefing.

Journal of microencapsulation

[No authors listed]
PMID: 16401584
J Microencapsul. 2005 Sep;22(6):689-93. doi: 10.1080/02652040500289452.

No abstract available.

Cite
Patent briefing. J Microencapsul. 2005;22(6):689-93doi: 10.1080/02652040500289452.
(2005). Patent briefing. Journal of microencapsulation, 22(6), 689-93. https://doi.org/10.1080/02652040500289452
"Patent briefing." Journal of microencapsulation vol. 22,6 (2005): 689-93. doi: https://doi.org/10.1080/02652040500289452
Patent briefing. J Microencapsul. 2005 Sep;22(6):689-93. doi: 10.1080/02652040500289452. PMID: 16401584.
Copy Download .nbib Format: NLM
Correction to: Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part I. Albumin-bound betulinic acid nanoparticles (ABBns).

Journal of microencapsulation

[No authors listed]
PMID: 28093010
J Microencapsul. 2016 Dec;33(8):i-ii. doi: 10.1080/02652048.2017.1281207.

No abstract available.

Cite
Correction to: Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part I. Albumin-bound betulinic acid nanoparticles (ABBns). J Microencapsul. 2016;33(8):i-iidoi: 10.1080/02652048.2017.1281207.
(2016). Correction to: Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part I. Albumin-bound betulinic acid nanoparticles (ABBns). Journal of microencapsulation, 33(8), i-ii. https://doi.org/10.1080/02652048.2017.1281207
"Correction to: Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part I. Albumin-bound betulinic acid nanoparticles (ABBns)." Journal of microencapsulation vol. 33,8 (2016): i-ii. doi: https://doi.org/10.1080/02652048.2017.1281207
Correction to: Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part I. Albumin-bound betulinic acid nanoparticles (ABBns). J Microencapsul. 2016 Dec;33(8):i-ii. doi: 10.1080/02652048.2017.1281207. PMID: 28093010.
Copy Download .nbib Format: NLM
Hyaluronic acid-coated and Olaparib-loaded PEI - PLGA nanoparticles for the targeted therapy of triple negative breast cancer.

Journal of microencapsulation

Hu H, Zhang Y, Ji W, Mei H, Wu T, He Z, Wang K, Shi C.
PMID: 34859741
J Microencapsul. 2021 Dec 20;1-12. doi: 10.1080/02652048.2021.2014586. Epub 2021 Dec 20.

AIM: To prepare the hyaluronic acid-coated Olaparib-loaded PEI - PLGA nanoparticles (HA-Ola-PPNPs) and investigate their tumour-targeted anticancer effect.METHODS: The synthesis of HA-Ola-PPNPs was verified by DLS, TEM and SEM, followed was measured its cytotoxicity using CCK-8 assay. Confocal microscopy...

Cite
Hu H, Zhang Y, Ji W, et al. Hyaluronic acid-coated and Olaparib-loaded PEI - PLGA nanoparticles for the targeted therapy of triple negative breast cancer. J Microencapsul. 2021;1-12doi: 10.1080/02652048.2021.2014586.
Hu, H., Zhang, Y., Ji, W., Mei, H., Wu, T., He, Z., Wang, K., & Shi, C. (2021). Hyaluronic acid-coated and Olaparib-loaded PEI - PLGA nanoparticles for the targeted therapy of triple negative breast cancer. Journal of microencapsulation, 1-12. https://doi.org/10.1080/02652048.2021.2014586
Hu, Huiping, et al. "Hyaluronic acid-coated and Olaparib-loaded PEI - PLGA nanoparticles for the targeted therapy of triple negative breast cancer." Journal of microencapsulation vol. (2021): 1-12. doi: https://doi.org/10.1080/02652048.2021.2014586
Hu H, Zhang Y, Ji W, Mei H, Wu T, He Z, Wang K, Shi C. Hyaluronic acid-coated and Olaparib-loaded PEI - PLGA nanoparticles for the targeted therapy of triple negative breast cancer. J Microencapsul. 2021 Dec 20;1-12. doi: 10.1080/02652048.2021.2014586. Epub 2021 Dec 20. PMID: 34859741.
Copy Download .nbib Format: NLM
An evaluative .

Journal of microencapsulation

Van Eyssen SR, Kavaz D.
PMID: 34632926
J Microencapsul. 2021 Nov-Dec;38(7):546-558. doi: 10.1080/02652048.2021.1992028. Epub 2021 Oct 21.

AIM: To synthesise cytarabine-loaded SLNs modified with the RGD peptide as a ligand, suitable for effective cancer therapy.METHODS: SLNs were synthesised by the high shear, hot homogenisation technique. A 2 level 3 factor analysis was used in optimisation. Particle...

Cite
Van Eyssen SR, Kavaz D. An evaluative . J Microencapsul. 2021;38(7):546-558doi: 10.1080/02652048.2021.1992028.
Van Eyssen, S. R., & Kavaz, D. (2021). An evaluative . Journal of microencapsulation, 38(7), 546-558. https://doi.org/10.1080/02652048.2021.1992028
Van Eyssen, Shelly Roselyn, and Kavaz, Doga. "An evaluative ." Journal of microencapsulation vol. 38,7 (2021): 546-558. doi: https://doi.org/10.1080/02652048.2021.1992028
Van Eyssen SR, Kavaz D. An evaluative . J Microencapsul. 2021 Nov-Dec;38(7):546-558. doi: 10.1080/02652048.2021.1992028. Epub 2021 Oct 21. PMID: 34632926.
Copy Download .nbib Format: NLM
Hydrophobic ion-pairing assembled liposomal Rhein with efficient loading for acute pancreatitis treatment.

Journal of microencapsulation

Zhang J, Wang S, Cai H, Feng T, Liu Z, Xu Y, Li J.
PMID: 34637365
J Microencapsul. 2021 Nov-Dec;38(7):559-571. doi: 10.1080/02652048.2021.1993363. Epub 2021 Oct 26.

AIM: The present study aimed to develop liposomal Rhein by employing a hydrophobic ion-pairing technique (HIP) for improved pancreatitis therapy.METHODS: F127 modified liposomal Rhein (F127-RPC-Lip) was prepared using a two-step process consisting of complexation first, followed by a film-ultrasonic...

Cite
Zhang J, Wang S, Cai H, et al. Hydrophobic ion-pairing assembled liposomal Rhein with efficient loading for acute pancreatitis treatment. J Microencapsul. 2021;38(7):559-571doi: 10.1080/02652048.2021.1993363.
Zhang, J., Wang, S., Cai, H., Feng, T., Liu, Z., Xu, Y., & Li, J. (2021). Hydrophobic ion-pairing assembled liposomal Rhein with efficient loading for acute pancreatitis treatment. Journal of microencapsulation, 38(7), 559-571. https://doi.org/10.1080/02652048.2021.1993363
Zhang, Jinjie, et al. "Hydrophobic ion-pairing assembled liposomal Rhein with efficient loading for acute pancreatitis treatment." Journal of microencapsulation vol. 38,7 (2021): 559-571. doi: https://doi.org/10.1080/02652048.2021.1993363
Zhang J, Wang S, Cai H, Feng T, Liu Z, Xu Y, Li J. Hydrophobic ion-pairing assembled liposomal Rhein with efficient loading for acute pancreatitis treatment. J Microencapsul. 2021 Nov-Dec;38(7):559-571. doi: 10.1080/02652048.2021.1993363. Epub 2021 Oct 26. PMID: 34637365.
Copy Download .nbib Format: NLM
Nanoparticle-loaded microcapsules providing effective UV protection for Cry1Ac.

Journal of microencapsulation

Zhang Y, Zhang A, Li M, He K, Guo S.
PMID: 34615422
J Microencapsul. 2021 Nov-Dec;38(7):522-532. doi: 10.1080/02652048.2021.1990424. Epub 2021 Oct 19.

AIM: To prepare several novel microcapsules using chitosan (Cs) and Alginate (Alg) as coating materials, and nano-ZnO, nano-SiOMETHODS: Microcapsules were prepared by the layer-by-layer (LbL) self-assembly technique and electrostatic adsorption. The morphologies were observed by scanning electron microscopy (SEM),...

Cite
Zhang Y, Zhang A, Li M, et al. Nanoparticle-loaded microcapsules providing effective UV protection for Cry1Ac. J Microencapsul. 2021;38(7):522-532doi: 10.1080/02652048.2021.1990424.
Zhang, Y., Zhang, A., Li, M., He, K., & Guo, S. (2021). Nanoparticle-loaded microcapsules providing effective UV protection for Cry1Ac. Journal of microencapsulation, 38(7), 522-532. https://doi.org/10.1080/02652048.2021.1990424
Zhang, Yongjing, et al. "Nanoparticle-loaded microcapsules providing effective UV protection for Cry1Ac." Journal of microencapsulation vol. 38,7 (2021): 522-532. doi: https://doi.org/10.1080/02652048.2021.1990424
Zhang Y, Zhang A, Li M, He K, Guo S. Nanoparticle-loaded microcapsules providing effective UV protection for Cry1Ac. J Microencapsul. 2021 Nov-Dec;38(7):522-532. doi: 10.1080/02652048.2021.1990424. Epub 2021 Oct 19. PMID: 34615422.
Copy Download .nbib Format: NLM
SMEDDS for improved oral bioavailability and anti-hyperuricemic activity of licochalcone A.

Journal of microencapsulation

Zhu Z, Liu J, Yang Y, Adu-Frimpong M, Ji H, Toreniyazov E, Wang Q, Yu J, Xu X.
PMID: 34338606
J Microencapsul. 2021 Nov-Dec;38(7):459-471. doi: 10.1080/02652048.2021.1963341. Epub 2021 Aug 15.

The aim of this study was to develop licochalcone A-loaded self-microemulsifying drug delivery system (LCA-SMEDDS) to improve bioavailability and anti-hyperuricemic activity of hydrophobic natural compound licochalcone A (LCA). The prepared LCA-SMEDDS was characterised by transmission electron microscopy analysis, particle...

Cite
Zhu Z, Liu J, Yang Y, et al. SMEDDS for improved oral bioavailability and anti-hyperuricemic activity of licochalcone A. J Microencapsul. 2021;38(7):459-471doi: 10.1080/02652048.2021.1963341.
Zhu, Z., Liu, J., Yang, Y., Adu-Frimpong, M., Ji, H., Toreniyazov, E., Wang, Q., Yu, J., & Xu, X. (2021). SMEDDS for improved oral bioavailability and anti-hyperuricemic activity of licochalcone A. Journal of microencapsulation, 38(7), 459-471. https://doi.org/10.1080/02652048.2021.1963341
Zhu, Zhongan, et al. "SMEDDS for improved oral bioavailability and anti-hyperuricemic activity of licochalcone A." Journal of microencapsulation vol. 38,7 (2021): 459-471. doi: https://doi.org/10.1080/02652048.2021.1963341
Zhu Z, Liu J, Yang Y, Adu-Frimpong M, Ji H, Toreniyazov E, Wang Q, Yu J, Xu X. SMEDDS for improved oral bioavailability and anti-hyperuricemic activity of licochalcone A. J Microencapsul. 2021 Nov-Dec;38(7):459-471. doi: 10.1080/02652048.2021.1963341. Epub 2021 Aug 15. PMID: 34338606.
Copy Download .nbib Format: NLM
Comparison of Virosome vs. Liposome as drug delivery vehicle using HepG2 and CaCo2 cell lines.

Journal of microencapsulation

Kumar V, Kumar R, Jain VK, Nagpal S.
PMID: 33719838
J Microencapsul. 2021 Aug;38(5):263-275. doi: 10.1080/02652048.2021.1902009. Epub 2021 Mar 25.

AIM: The present work involves encapsulation of herbal drug nanocurcumin into the virosomes and compared with a liposome in terms of their in vitro anti-proliferative, anti-inflammatory, and anti-migratory efficacy.METHODS: The anti-proliferative, anti-inflammatory, and anti-migratory efficacy of virosome and liposome...

Cite
Kumar V, Kumar R, Jain VK, et al. Comparison of Virosome vs. Liposome as drug delivery vehicle using HepG2 and CaCo2 cell lines. J Microencapsul. 2021;38(5):263-275doi: 10.1080/02652048.2021.1902009.
Kumar, V., Kumar, R., Jain, V. K., & Nagpal, S. (2021). Comparison of Virosome vs. Liposome as drug delivery vehicle using HepG2 and CaCo2 cell lines. Journal of microencapsulation, 38(5), 263-275. https://doi.org/10.1080/02652048.2021.1902009
Kumar, Varun, et al. "Comparison of Virosome vs. Liposome as drug delivery vehicle using HepG2 and CaCo2 cell lines." Journal of microencapsulation vol. 38,5 (2021): 263-275. doi: https://doi.org/10.1080/02652048.2021.1902009
Kumar V, Kumar R, Jain VK, Nagpal S. Comparison of Virosome vs. Liposome as drug delivery vehicle using HepG2 and CaCo2 cell lines. J Microencapsul. 2021 Aug;38(5):263-275. doi: 10.1080/02652048.2021.1902009. Epub 2021 Mar 25. PMID: 33719838.
Copy Download .nbib Format: NLM
Correction to: Erukula and Chatterjee, Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns).

Journal of microencapsulation

[No authors listed]
PMID: 27744740
J Microencapsul. 2016 Sep;33(6):i-ii. doi: 10.1080/02652048.2016.1231656. Epub 2016 Oct 17.

No abstract available.

Cite
Correction to: Erukula and Chatterjee, Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns). J Microencapsul. 2016;33(6):i-iidoi: 10.1080/02652048.2016.1231656.
(2016). Correction to: Erukula and Chatterjee, Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns). Journal of microencapsulation, 33(6), i-ii. https://doi.org/10.1080/02652048.2016.1231656
"Correction to: Erukula and Chatterjee, Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns)." Journal of microencapsulation vol. 33,6 (2016): i-ii. doi: https://doi.org/10.1080/02652048.2016.1231656
Correction to: Erukula and Chatterjee, Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns). J Microencapsul. 2016 Sep;33(6):i-ii. doi: 10.1080/02652048.2016.1231656. Epub 2016 Oct 17. PMID: 27744740.
Copy Download .nbib Format: NLM
Hyaluronic acid-coated and Olaparib-loaded PEI - PLGA nanoparticles for the targeted therapy of triple negative breast cancer.

Journal of microencapsulation

Hu H, Yu Z, Ji W, Mei H, Wu T, He Z, Wang K, Shi C.
PMID: 34859741
J Microencapsul. 2021 Dec 03;1-25. doi: 10.1080/02652048.2021.2014586. Epub 2021 Dec 03.

AIM: To prepare the hyaluronic acid-coated Olaparib-loaded PEI - PLGA nanoparticles (HA-Ola-PPNPs) and investigate their tumor-targeted anticancer effect.METHODS: The synthesis of HA-Ola-PPNPs was verified by DLS, TEM and SEM, followed was measured its cytotoxicity using CCK-8 assay. Confocal microscopy...

Cite
Hu H, Yu Z, Ji W, et al. Hyaluronic acid-coated and Olaparib-loaded PEI - PLGA nanoparticles for the targeted therapy of triple negative breast cancer. J Microencapsul. 2021;1-25doi: 10.1080/02652048.2021.2014586.
Hu, H., Yu, Z., Ji, W., Mei, H., Wu, T., He, Z., Wang, K., & Shi, C. (2021). Hyaluronic acid-coated and Olaparib-loaded PEI - PLGA nanoparticles for the targeted therapy of triple negative breast cancer. Journal of microencapsulation, 1-25. https://doi.org/10.1080/02652048.2021.2014586
Hu, Huiping, et al. "Hyaluronic acid-coated and Olaparib-loaded PEI - PLGA nanoparticles for the targeted therapy of triple negative breast cancer." Journal of microencapsulation vol. (2021): 1-25. doi: https://doi.org/10.1080/02652048.2021.2014586
Hu H, Yu Z, Ji W, Mei H, Wu T, He Z, Wang K, Shi C. Hyaluronic acid-coated and Olaparib-loaded PEI - PLGA nanoparticles for the targeted therapy of triple negative breast cancer. J Microencapsul. 2021 Dec 03;1-25. doi: 10.1080/02652048.2021.2014586. Epub 2021 Dec 03. PMID: 34859741.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 58 entries